Modification of the functional capacity of sarcoplasmic reticulum membranes in patients suffering from chronic fatigue syndrome

Reid, 2000, Chronic fatigue syndrome, Br Med J, 320, 292, 10.1136/bmj.320.7230.292 Fukuda, 1994, The chronic fatigue syndrome: a comprehensive approach to its definition and study, Ann Intern Med, 121, 953, 10.7326/0003-4819-121-12-199412150-00009 Sharpe, 1991, A report-chronic fatigue syndrome: guidelines for research, J R Soc Med, 84, 118, 10.1177/014107689108400224 Straus, 1985, Persisting illness and fatigue in adults with evidence of Epstein–Barr virus infection, Ann Intern Med, 102, 7, 10.7326/0003-4819-102-1-7 Landay, 1991, Chronic fatigue syndrome: clinical condition associated with immune activation, Lancet, 338, 707, 10.1016/0140-6736(91)91440-6 Wessely, 1995, The epidemiology of chronic fatigue syndrome, Epidemiol Rev, 17, 139, 10.1093/oxfordjournals.epirev.a036170 Wessely, 1997, The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study, Am J Public Health, 87, 1449, 10.2105/AJPH.87.9.1449 Lawrie, 1995, Chronic fatigue syndrome in the community. Prevalence and associations, Br J Psychiatry, 166, 793, 10.1192/bjp.166.6.793 Richards, 2000, Free radicals in chronic fatigue syndrome: cause or effect?, Redox Rep, 5, 146, 10.1179/135100000101535519 Richards, 2000, Blood parameter indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome, Redox Rep, 5, 35, 10.1179/rer.2000.5.1.35 Vecchiet, 1996, Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome, Neurosci Lett, 208, 117, 10.1016/0304-3940(96)12559-3 Fulle, 2000, Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome, Free Radic Biol Med, 29, 1252, 10.1016/S0891-5849(00)00419-6 Mecocci, 1999, Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle, Free Radic Biol Med, 26, 303, 10.1016/S0891-5849(98)00208-1 Keenoy, 2000, Magnesium status and parameters of the oxidant-antioxidant balance in patients with chronic fatigue: effects of supplementation with magnesium, J Am Coll Nutr, 19, 374, 10.1080/07315724.2000.10718934 Pall, 2001, Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite, Med Hypotheses, 57, 139, 10.1054/mehy.2001.1325 Belia, 1998, Sodium nitroprusside, a NO donor, modifies Ca2+ transport and mechanical properties in frog skeletal muscle, J Muscle Res Cell Motil, 19, 865, 10.1023/A:1005499606155 Krupp, 1996, Mechanisms and management of fatigue in progressive neurological disorders, Curr Opin Neurol, 9, 456, 10.1097/00019052-199612000-00011 Chaudhuri, 2000, The symptoms of chronic fatigue syndrome are related to abnormal ion channel function, Med Hypotheses, 54, 59, 10.1054/mehy.1998.0822 Stuart, 1992, Photooxidation of skeletal muscle sarcoplasmic reticulum induces rapid calcium release, Arch Biochem Biophys, 292, 512, 10.1016/0003-9861(92)90024-Q Holmes, 1988, Chronic fatigue syndrome: a working case definition, Ann Intern Med, 108, 387, 10.7326/0003-4819-108-3-387 Engel, 1994, The muscle biopsy, 822 Fanò, 2001, Age and sex influence on oxidative damage and functional status in human skeletal muscle, J Muscle Res Cell Motil, 22, 345, 10.1023/A:1013122805060 Shinitzky, 1978, Fluidity parameters of lipid regions determined by fluorescence polarization, Biochim Biophys Acta, 515, 367, 10.1016/0304-4157(78)90010-2 Renganathan, 1997, Dihydropyridine receptor-ryanodine receptor uncoupling in aged skeletal muscle, J Membr Biol, 157, 247, 10.1007/s002329900233 Treves, 1997, Interaction of S100A1 with the Ca2+ release channel (ryanodine receptor) of skeletal muscle, Biochemistry, 36, 11496, 10.1021/bi970160w Fanò, 1989, Functional aspects of calcium transport in sarcoplasmic reticulum vesicles derived from frog skeletal muscle treated with saponin, J Muscle Res Cell Motil, 10, 326, 10.1007/BF01758428 Rock, 1990, Abnormal fluidity state in membrane of malignant hyperthermia pig skeletal muscle, Arch Biochem Biophys, 281, 36, 10.1016/0003-9861(90)90409-R Lowry, 1951, Protein measurement with folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 Taussky, 1952, A microcolorimetric method for the determination of inorganic phosphorus, J Biol Chem, 202, 675, 10.1016/S0021-9258(18)66180-0 Carmody, 2001, FKBP12 associates tightly with the skeletal muscle type 1 ryanodine receptor, but not with other intracellular calcium release channels, FEBS Lett, 505, 97, 10.1016/S0014-5793(01)02787-9 Keenoy, 2001, Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome, Life Sci, 68, 2037, 10.1016/S0024-3205(01)01001-3 Takagi, 1971, Lipid composition of sarcoplasmic reticulum of human skeletal muscle, Biochim Biophys Acta, 248, 12, 10.1016/0005-2760(71)90069-5 Marsili, 1992, S-100ab increases Ca2+ release in purified sarcoplasmic vesicles of frog skeletal muscle, J Muscle Res Cell Motil, 13, 511, 10.1007/BF01737993 Sun, 2001, Classes of thiols that influence the activity of the skeletal muscle calcium release channel, J Biol Chem, 276, 15625, 10.1074/jbc.M100083200 Loke, 1998, Malignant hyperthermia and central core disease: disorders of Ca2+ release channels, Am J Med, 104, 470, 10.1016/S0002-9343(98)00108-9 Ikemoto, 2000, The luminal Ca2+ transient controls Ca2+ release/re-uptake of sarcoplasmic reticulum, Biochem Biophys Res Commun, 279, 858, 10.1006/bbrc.2000.4031 Pickar, 1991, Apparent upregulation of Na+,K+ pump sites in SHR skeletal muscle with reduced transport capacity, Clin Exp Hypertens A, 13, 645, 10.3109/10641969109042067 Pickar, 1997, Decreased [3H]ouabain binding sites in skeletal muscle of rats with chronic heart failure, J Appl Physiol., 83, 323, 10.1152/jappl.1997.83.1.323